Dec 08, 2020
Thinking about buying stock in Pfizer, Nio, Lexicon Pharmaceuticals, Oncolytics Biotech, or Boeing?
Jun 04, 2020
Oncolytics Biotech® Provides Recap of Key Opinion Leader Call Highlighting the Induction of Rapid and Persistent Immune Responses With Systemic Pelareorep Treatment
May 29, 2020
Oncolytics Biotech® Presents Clinical Proof-of-Concept Data in Multiple Myeloma at the ASCO Virtual Annual Meeting
May 26, 2020
Oncolytics Biotech® Presents Clinical Data Supporting a Predictive Biomarker of Pelareorep Response in Breast Cancer at the ESMO Breast Cancer Virtual Meeting
May 13, 2020
Oncolytics Biotech® to Present at the RBC Global Healthcare Conference
May 08, 2020
Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders
Apr 30, 2020
Oncolytics Biotech® Announces Changes to Annual General Meeting
Apr 17, 2020
Oncolytics Biotech® Updates Clinical Development and Operations Activities During the COVID-19 Pandemic
Apr 02, 2020
Oncolytics Biotech® Announces Publication of Pelareorep's Clinical Benefit Against KRAS Mutated Colorectal Cancer
Mar 24, 2020
Oncolytics Biotech® Announces Favourable AWARE-1 Safety Update
Mar 05, 2020
Oncolytics Biotech® Reports Fourth Quarter and Full Year 2019 Financial Results and Operational Highlights
Mar 04, 2020
Advances in Treatments are Leading to a Decline in Deaths from Cancer
Feb 28, 2020
Accidental T-cell Discovery Represents "A New Frontier" in Cancer Treatment
Feb 28, 2020
Accidental T-cell Discovery Represents "A New Frontier" in Cancer Treatment
Feb 26, 2020
Study Shows Surprisingly Low Number of Patients Seek Trials to Treat Cancer
Feb 25, 2020
IO Biotech Announces Positive Outcome of Interim Analysis of Phase 2 Randomized Trial in First Line Non-small Cell Lung Cancer
Jan 29, 2020
Several Drugmakers are Racing to Create and Test a Vaccine for China's Deadly Coronavirus
Jan 27, 2020
Oncolytics Biotech® Announces Statistically Significant Data Identifying CEACAM6 as a Prospective Prognostic Biomarker for Pelareorep in the Treatment of Pancreatic Adenocarcinoma
Jan 27, 2020
Biotech Brief: Demand is Growing for Safer, More-Efficacious Drugs When Treating Pancreatic Cancer
Jan 22, 2020
Hopeful New Therapies For Pancreatic Cancer Expected to be a Big Boon for Biotechs